Please use this identifier to cite or link to this item:
Title: An optofluidic approach for gold nanoprobes based-cancer theranostics
Authors: Panwar, Nishtha
Song, Peiyi
Yang, Chengbin
Yong, Ken-Tye
Tjin, Swee Chuan
Keywords: Gold Nanorods
Flow Cytometry
Issue Date: 2017
Source: Panwar, N., Song, P., Yang, C., Yong, K.-T., & Tjin, S. C. (2017). An optofluidic approach for gold nanoprobes based-cancer theranostics. Proceedings of SPIE - Microfluidics, BioMEMS, and Medical Microsystems XV, 10061, 100610L-.
Conference: Proceedings of SPIE - Microfluidics, BioMEMS, and Medical Microsystems XV
Abstract: Suppression of overexpressed gene mutations in cancer cells through RNA interference (RNAi) technique is a therapeutically effective modality for oncogene silencing. In general, transfection agent is needed for siRNA delivery. Also, it is a tedious and time consuming process to analyze the gene transfection using current conventional flow cytometry systems and commercially available transfection kits. Therefore, there are two urgent challenges that we need to address for understanding and real time monitoring the delivery of siRNA to cancer cells more effectively. One, nontoxic, biocompatible and stable non-viral transfection agents need to be developed and investigated for gene delivery in cancer cells. Two, new, portable optofluidic methods need to be engineered for determining the transfection efficiency of the nanoformulation in real time. First, we demonstrate the feasibility of using gold nanorods (AuNRs) as nanoprobes for the delivery of Interleukin-8 (IL-8) siRNA in a pancreatic cancer cell line- MiaPaCa-2. An optimum ratio of 10:1 for the AuNRs–siRNA nanoformulation required for efficient loading has been experimentally determined. Promising transfection rates (≈88%) of the nanoprobe-assisted gene delivery are quantified by flow cytometry and fluorescence imaging, which are higher than the commercial control, Oligofectamine. The excellent gene knockdown performance (over 81%) of the proposed model support in vivo trials for RNAi-based cancer theranostics. In addition to cancer theranostics, our nanoprobe combination can be also applied for disease outbreak monitoring like MERS. Second, we present an optical fiber-integrated microfluidic chip that utilizes simple hydrodynamic and optical setups for miniaturized on-chip flow cytometry. The chip provides a powerful and convenient tool to quantitatively determine the siRNA transfection into cancer cells without using bulky flow cytometer. These studies outline the role of AuNRs as potential non-viral gene delivery vehicles, and their suitability for microfluidics-based lab-on-chip flow cytometry applications.
DOI: 10.1117/12.2251366
Schools: School of Electrical and Electronic Engineering 
Rights: © 2017 Society of Photo-Optical Instrumentation Engineers (SPIE). This paper was published in Proceedings of SPIE - Microfluidics, BioMEMS, and Medical Microsystems XV and is made available as an electronic reprint (preprint) with permission of Society of Photo-Optical Instrumentation Engineers (SPIE). The published version is available at: []. One print or electronic copy may be made for personal use only. Systematic or multiple reproduction, distribution to multiple locations via electronic or other means, duplication of any material in this paper for a fee or for commercial purposes, or modification of the content of the paper is prohibited and is subject to penalties under law.
Fulltext Permission: open
Fulltext Availability: With Fulltext
Appears in Collections:EEE Conference Papers

Files in This Item:
File Description SizeFormat 
An optofluidic approach for gold nanoprobes basedcancer theranostics.pdf3.92 MBAdobe PDFThumbnail

Page view(s)

Updated on Feb 19, 2024

Download(s) 20

Updated on Feb 19, 2024

Google ScholarTM




Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.